ISO TS 21560-2020 PDF

ISO TS 21560-2020 PDF

General requirements of tissue-engineered medical products

$48.00 $96.00 -50%
Product Code: ISO TS 21560
Stock In Stock
Edition: 1ST
Published: 08/2020
Number of Pages: 18
File Size: 1 file, 1 Byte

Available Options

Product Description

General requirements of tissue-engineered medical products

Introduction: Advances in the field of biological sciences have made possible the generation of a new type of medical product that when administered to the human body, may repair, replace, regenerate or enhance the function of impaired tissues or organs. Extensive experience acquired through the administration of living human cells has yielded solid knowledge about the quality requirements and the risks associated with their use. However, the development of tissue-engineered medical products (TEMPs) that are not simply obtained from a human donor or by separating living tissues, but rather are grown from various cell sources and are manipulated during manufacture to meet the medical needs of the patient, introduces new challenges with regard to quality requirements and risk management for the benefit of patients. TEMPs utilizing human material are quite diverse but share a set of common quality requirements for their safe use. These kinds of products require special attention for contamination control, such as infectious agents transmitting disease (e.g. hepatitis, HIV, TSE) and harmful chemicals, unintended decomposition or degradation induced by inappropriate handling at any stage of the manufacturing process, tumorigenic potential, induction of an immunogenic reaction in the recipient, traceability of cells, critical materials, and the final product are key to product quality and its safe use. This document has been developed with the objective of assisting interested parties, such as m

Scope: This document specifies general requirements for tissue-engineered medical products (TEMPs), which are used in regenerative medicine. With regard to safety, this document outlines requirements for materials, manufacture, quality control, and unintentional biological effects elicited by TEMPs. This document does not address requirements for clinical trials and efficacy. This document is not applicable to tissue-engineered products used for diagnosis, ex-vivo testing or extracorporeal treatments of patients (e.g. dialysis with TEMP components). TEMPs containing viable xenogenic cells, genetically modified cells, or cells derived from abnormal cells or tissues (e.g. cancerous tissues) are also excluded from the scope. The combination of TEMPs with medical devices, with the exception of scaffolds comprised of synthetic and/or naturally-derived (e.g. animal sourced) materials, is also excluded from the scope. NOTE International, national or regional regulations or requirements, or the Pharmacopeia also apply to specific topics covered in this document.

Be the first to write a review for this product.

Write a review

Note: HTML is not translated!
Bad           Good
ISO TS 21560-2020 PDF

ISO TS 21560-2020 PDF

$48.00 $96.00